Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/119368
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParkinson, B.-
dc.contributor.authorElshaug, A.G.-
dc.date.issued2016-
dc.identifier.citationPharmacoEconomics, 2016; 34(4):421-422-
dc.identifier.issn1170-7690-
dc.identifier.issn1179-2027-
dc.identifier.urihttp://hdl.handle.net/2440/119368-
dc.description.statementofresponsibilityBonny Parkinson, Adam G. Elshaug-
dc.language.isoen-
dc.publisherAdis International-
dc.rights© Springer International Publishing Switzerland 2016-
dc.source.urihttp://dx.doi.org/10.1007/s40273-016-0383-2-
dc.subjectHealth outcome; decision maker; clinical indication; economic cooperation-
dc.titleAuthors’ reply to Palozzo and Messori: ‘‘Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review’’-
dc.typeJournal article-
dc.identifier.doi10.1007/s40273-016-0383-2-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1109626-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1104136-
pubs.publication-statusPublished-
dc.identifier.orcidElshaug, A.G. [0000-0002-4939-5379]-
Appears in Collections:Aurora harvest 4
Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.